Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin)

[ad_1] This section is Partnership Content supplied The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia…